Onyx.cover_-1.jpg

Onyx participates in World Orphan Drugs Congress in Washington

Following a successful presentation at the Cell Therapy Manufacturing and Gene Therapy Congress in Brussels, Onyx has again had a strong presence at the prestigious World Orphan Drugs Congress in Washington. This emphasises Onyx strong and continuing commitment to the areas of orphan drugs, rare and ultra-rare diseases and regenerative medicine including cell and gene therapies.

Prime GlobalOnyx participates in World Orphan Drugs Congress in Washington
Share this post

Join the conversation

Related Posts